Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers. - Wikidata - awgldk - TriplyDB

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

http://www.wikidata.org/entity/Q35000796

about

Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer Outcomes of endoscopic pyloric stenting in malignant gastric outlet obstruction: a retrospective study A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable distal malignant biliary obstruction: a multicenter feasibility study.Improvement of prognosis for unresectable biliary tract cancer.Current status of chemotherapy for the treatment of advanced biliary tract cancer.Chemotherapy for the biliary tract cancers: moving toward improved survival time.The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines.Japanese multicenter estimation of WallFlex duodenal stent for unresectable malignant gastric outlet obstruction.Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstruction.

P2860

Q34779286-469E1A75-D813-4FCE-8CDA-AFC813715F91 Q34839721-39793899-0477-4141-BEBF-4EE5190BA259 Q35061603-081ADAEE-F5C5-4D57-B0C4-255EC2072A1F Q36525533-B2F126C7-B888-4748-BB56-E4116A0A077E Q37138732-1B11887C-8946-47C6-8972-A3B976420ACC Q37983498-8E89EE8F-EC6A-4F4F-832A-D065F9F22D97 Q39422598-CF177E95-EC01-43D7-90A4-A797E9AB5608 Q45892892-A18CE142-47D7-4E6A-9C2D-AD3CC6EB121A Q53509752-71AF357C-0C98-43A4-B66E-90AACD8AB070

P2860

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

http://www.wikidata.org/entity/Q35000796

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

@ast

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

@en

type

label

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

@ast

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

@en

prefLabel

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

@ast

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

@en

P1433

Q35000796-1D7A37B2-6A19-4B22-83D1-D51006F24B60

P1476

Q35000796-A31D41DB-2FD2-4F72-BE99-E5BB055734E2

P2093

Q35000796-078B362A-FE93-4568-81CD-F4B239A962F5

Q35000796-0D7FEADF-F08F-486D-9470-7221486AE952

Q35000796-1F2B634E-A0DE-4978-BDF6-828729E55AD6

Q35000796-2E8E1202-05A9-49C5-AE12-77F73757186C

Q35000796-3026AD69-08A4-490E-9313-C995524465D3

Q35000796-4973F253-A50F-4929-B6F1-C1C7E8D04F13

Q35000796-4BADB8A0-D626-4BDC-8590-B82CC05C7A83

Q35000796-59032328-7699-495F-A356-0C644E3179FA

Q35000796-62376E87-0C29-46D7-99F7-4F2CBFAF750C

Q35000796-65C70638-D95F-4242-8C02-00CF65D36CCD

P2860

Q35000796-0D8E7D48-579F-4692-98CB-74A9BBE6711D

Q35000796-126794AB-358D-4F1A-8ADB-6B171EC3A79B

Q35000796-144BC2F3-834A-4AEA-AFC7-36D38DB91CC4

Q35000796-14C4722D-14B3-4C5F-84C0-23CE2492D009

Q35000796-28A8BD5C-ECB6-469A-B525-3216C9CEA731

Q35000796-471D3CB5-841A-4FDA-9120-0EA6021DD28B

Q35000796-479A18FC-EF78-4441-97CD-C2C223F4712E

Q35000796-4D8975A5-1C52-4109-9A0C-3582A598AE3C

Q35000796-57B3A6F0-CDB7-4BFA-814F-33495FC86537

Q35000796-5A38EE77-5DF2-4A0C-869C-63C9776989C3

P304

Q35000796-07E752A8-ABB7-41B4-B619-8668BDB05E07

P31

Q35000796-E0E95134-4756-40AE-AD6C-259D76EE11B7

P356

Q35000796-C0878C15-3290-482A-9CFC-17255BFB5376

P433

Q35000796-CD5B7D9B-8292-4DA8-A543-9D007AAB8417

P478

Q35000796-24560F91-CB9D-4DAB-BA72-AA0CC285922B

P50

Q35000796-928DDE5E-6356-474E-80AB-0451187058BA

P577

Q35000796-52458B73-C404-4FCC-B220-0723A67D0274

P5875

Q35000796-4F44ACDE-9012-4EEE-8417-1392C2CB1224

P698

Q35000796-1EFFA71B-A894-45FE-8107-4C808F8CAA84

P921

Q35000796-41C1A7F9-3D76-48A9-B7EE-96580D4EAF73

P932

Q35000796-892715F3-2935-4984-A80D-5A143CEC1453

P356

P1433

World journal of clinical oncology

P1476

Recent progress and limitations of chemotherapy for pancreatic and biliary tract cancers.

@en

P2093

Dai Mohri

http://www.w3.org/2001/XMLSchema#string

Hideaki Ijichi

http://www.w3.org/2001/XMLSchema#string

Hirofumi Kogure

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Isayama

http://www.w3.org/2001/XMLSchema#string

Kazumichi Kawakubo

http://www.w3.org/2001/XMLSchema#string

Keishuke Tateishi

http://www.w3.org/2001/XMLSchema#string

Keisuke Yamamoto

http://www.w3.org/2001/XMLSchema#string

Kenji Hirano

http://www.w3.org/2001/XMLSchema#string

Koji Miyabayashi

http://www.w3.org/2001/XMLSchema#string

Masao Omata

http://www.w3.org/2001/XMLSchema#string

P2860

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.

S-1 monotherapy in patients with advanced biliary tract cancer.

Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer.

Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer.

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

P304

158-163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V2.I3.158

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51163846

http://www.w3.org/2001/XMLSchema#string

P698

21611090

http://www.w3.org/2001/XMLSchema#string

P921

P932

3100481

http://www.w3.org/2001/XMLSchema#string